CODEXIS filed a $100 million initial public offering (IPO). CODEXIS based in the United States is a joint partnership of industry leading biotechnology and energy companies such as Bio One Capital, DYADIC INTERNATIONAL, General Electric Energy, Maxygen, Pfizer, Royal Dutch/Shell, Chevron Biofuels, CMEA Capital, and FirstMark Capital. The IPO was underwritten by investment banking leaders Credit Suisse and Goldman Sachs. READ»